Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / Senate Bills / S. 250

S. 250

To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2021-02-044.1K⠃⠗⠋